Skip to content
  • The drug push

    Science Magazine - 05/22/2015

    This past January, microbiologists Kim Lewis and Slava Epstein reported the discovery of teixobactin, a compound that in lab dishes kills several antibiotic-resistant strains of bacteria. Media outlets heralded the discovery, announced in Nature, as a new solution to the growing problem of antimicrobial resistance. A White House press release mentioned teixobactin, which Lewis and Epstein, both of Northeastern University in Boston, had isolated from soil bacteria, as the “kind of innovative research” it aims to promote with a $1.2 billion antibiotics budget initiative. And Lewis and Epstein were repeatedly asked: “When will this be in the clinic?”

  • Cookies on Northeastern sites

    This website uses cookies and similar technologies to understand your use of our website and give you a better experience. By continuing to use the site or closing this banner without changing your cookie settings, you agree to our use of cookies and other technologies. To find out more about our use of cookies and how to change your settings, please go to our Privacy Statement.